M 1 (Methotrexate 2.5 mg)

Pill imprint M 1 has been identified as Methotrexate sodium 2.5 mg.

Methotrexate is used in the treatment of rheumatoid arthritis; psoriatic arthritis; psoriasis; acute lymphoblastic leukemia; acute lymphocytic leukemia (and more), and belongs to the drug classes antimetabolites, antipsoriatics, antirheumatics, other immunosuppressants. Not for use in pregnancy. Methotrexate 2.5 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for M 1

Methotrexate sodium 2.5 mg M 1
Methotrexate sodium 2.5 mg M 1  Front
Methotrexate sodium 2.5 mg M 1  Back
Methotrexate sodium 2.5 mg M 1
Methotrexate sodium
Imprint:
M 1
Strength:
2.5 mg
Color:
Yellow
Size:
6.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Antimetabolites
Antipsoriatics
Antirheumatics
Other immunosuppressants
Pregnancy Category:
X - Not for use in pregnancy
CSA Schedule:
N - Not a controlled drug
Manufacturer:
DAVA Pharmaceuticals, Inc.
National Drug Code (NDC):
67253-0320
Inactive Ingredients:
lactose
magnesium stearate
corn starch
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
00904-6012 Major Pharmaceuticals
67253-0580 DAVA Pharmaceuticals, Inc.

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web2)